86
“The supply bottlenecks for Tamoxifen have shown how dangerous the combination of few providers and extremely low reimbursement prices is for the care of cancer patients,” emphasized Thomas Weigold (Country President Sandoz Germany and Deputy Chairman of Pro Generika) at the 36th German Cancer Congress . “It is only thanks to the efforts of generic drug companies that…
Those